Presenting Your Gene Therapy Manufacturing Plan to Investors: What They Expect in 2026...
Genes of Interest, our employee spotlight showcasing the individuals behind Forge that...
Celebrating the Women at Forge and Their Stories During Women's History Month
The History of AAV Gene Therapy: From Scientific Concept to Commercial Manufacturing
Marking National Biotechnology Month With Reflections From Our Leaders
23 Questions with Ron & Mark on Forge's Facility Dedicated to AAV Manufacturing
A New Window Into FDA’s Approach to Bespoke Therapies: Signals, Open Questions, and Our...
Potency Assays for Cell and Gene Therapy: A Complete Guide
Inside FDA’s PreCheck Public Meeting: Why It Matters for CGT Developers Authors: Forge...
Design It Right: Evaluating AAV Manufacturability Through Molecular and Upstream...
